Health - Google News: Palatin says partner AstraZeneca drops obesity drug - Reuters

Health - Google News Google News

Palatin says partner AstraZeneca drops obesity drug - Reuters Sep 7th 2012, 14:30 Proactive Investors USA & Canada Palatin says partner AstraZeneca drops obesity drug Reuters (Reuters) - Palatin Technologies Inc said its research partner AstraZeneca Plc decided to end the development of an experimental obesity drug due to an allergic reaction that may be linked to the compound. Palatin's shares fell as much as 5 percent to ... Safety threat forces AstraZeneca to scuttle obesity programFierceBiotech Palatin says AstraZeneca stops development of AZD2820 obesity drugProactive Investors USA & Canada Phase I Anti-Obesity Candidate Dropped on Safety GroundsGenetic Engineering News NASDAQ -Sacramento Bee all 25 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: